LSA
UTHR icon

Leonteq Securities AG’s United Therapeutics UTHR Stock Holding History

Leonteq Securities AG’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Sell
68
-50
-42% -$28.2K ﹤0.01% 862
2026
Q1 		$70K Sell
118
-67
-36% -$33.4K ﹤0.01% 800
2025
Q4 		$90.1K Buy
185
+6
+3% +$2.79K ﹤0.01% 823
2025
Q3 		$75K Sell
179
-232
-56% -$78K ﹤0.01% 808
2025
Q2 		$118K Buy
411
+39
+10% +$11.7K ﹤0.01% 690
2025
Q1 		$116K Sell
372
-19
-5% -$6.51K 0.01% 662
2024
Q4 		$138K Sell
391
-67
-15% -$24.6K 0.01% 618
2024
Q3 		$164K Buy
458
+147
+47% +$49.7K 0.01% 527
2024
Q2 		$99.1K Buy
311
+24
+8% +$6.35K 0.01% 625
2024
Q1 		$65.9K Buy
287
+187
+187% +$42.2K ﹤0.01% 722
2023
Q4 		$22K Buy
+100
New +$23K ﹤0.01% 926
2023
Q3 		– Sell
-100
Closed -$22.1K – 1296
2023
Q2 		$22.1K Sell
100
-42
-30% -$9.3K ﹤0.01% 959
2023
Q1 		$31.8K Buy
142
+42
+42% +$10.4K ﹤0.01% 881
2022
Q4 		$27.8K Hold
100
– – ﹤0.01% 930
2022
Q3 		$20.9K Hold
100
– – ﹤0.01% 952
2022
Q2 		$23.6K Hold
100
– – ﹤0.01% 954
2022
Q1 		$17.9K Hold
100
– – ﹤0.01% 1019
2021
Q4 		$21.6K Sell
100
-135
-57% -$26.5K ﹤0.01% 1031
2021
Q3 		$43.4K Buy
+235
New +$46.3K ﹤0.01% 871

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Leonteq Securities AG's UTHR Position: Q2 2026 in Review

Leonteq Securities AG reduced its United Therapeutics (UTHR) stake by 42% in Q2 2026, selling an estimated $28.2K and leaving 68 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Leonteq Securities AG first reported a position in UTHR in Q3 2021 and has held it in 19 quarters since. The position peaked at $164K in Q3 2024. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Leonteq Securities AG held 68 shares of United Therapeutics worth $36.8K as of Q2 2026.
  • Leonteq Securities AG sold 50 United Therapeutics shares in Q2 2026, an estimated $28.2K.
  • United Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #862 holding.
  • Leonteq Securities AG first reported a position in United Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Leonteq Securities AG's United Therapeutics position peaked at $164K in Q3 2024.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.